Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Collapsed Microbiome Biotech Sells Off Assets

Microbiome illustration

A developer of therapies addressing the body’s microbe communities is selling off key assets to another biotechnology company, after problems developed with its lead program. . . . → Read More: Collapsed Microbiome Biotech Sells Off Assets

Biomanufacturing Company Gains $9.5M in Early Funds

A company offering a biomanufacturing process it says is more efficient and scalable than conventional bio-production methods is raising $9.5 million in its first venture round. . . . → Read More: Biomanufacturing Company Gains $9.5M in Early Funds

Small Biz Grant Supports Regenerative Alzheimer’s Treatment

Healthy neuron illustration

A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment

Venture Firm, Cancer Center Start Antibody Biotech Company

Antibody illustration

A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company

HHS Directs $100M for Covid-19 Venture Investments

Global Covid-19

The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments

Digital Chemistry Start-Up Gains $43M in Early Funds

Molecule model in an open hand

A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round. . . . → Read More: Digital Chemistry Start-Up Gains $43M in Early Funds

Companies Partner on Fast Production of Biologics in Plants

Flowering Nicotiana benthamiana plant

The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities. . . . → Read More: Companies Partner on Fast Production of Biologics in Plants

Darpa Seeking On-Demand, Distributed Production of Proteins

Aerial view of the Pentagon in Washington, D.C.

A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins. . . . → Read More: Darpa Seeking On-Demand, Distributed Production of Proteins

Synthetic Bio Company Manufactures Research Cells

Healthy neuron illustration

A synthetic biology company says it can now produce engineered cells from stem cells for research to precise specifications, and in large quantities and consistent quality. . . . → Read More: Synthetic Bio Company Manufactures Research Cells

Partnership to Mass-Produce Graphene Biosensors

Graphene illustration

A biological testing device company and industrial graphene manufacturer are collaborating on large-scale production of graphene biosensors for widespread use. . . . → Read More: Partnership to Mass-Produce Graphene Biosensors